Thyroid gland suppressibility in patients treated with radioiodine for diffuse toxic goiter
Burgos, F.L.; Micames, C.; Rivera, J.V.
Boletin de la Asociacion Medica de Puerto Rico 75(4): 173-175
1983
ISSN/ISBN: 0004-4849 PMID: 6575791 Document Number: 701497
Document emailed within 1 workday
Related Documents
Alekseeva, R.M.; Slavina, L.S. 1971: Electrocardiographic changes in children with diffuse toxic goiter before treatment and in the remote period after subtotal resection of the thyroid gland Voprosy Okhrany Materinstva i Detstva 16(11): 91Lipets, A.I.; Dozorets, I.L.; Seleznev, L.E. 1971: Dynamics of some indices of the glucocorticoid function of the adrenal cortex in patients with a severe form of diffuse toxic goiter under the effect of radioiodine treatment Sovetskaia Meditsina 34(9): 63-65
Hackenberg, K.; Schneider, K.R.; Reinwein, D. 1972: Suppressibility of the thyroid gland during drug therapy of hyperthyroidism. Significance of goiter size and thyroglobulin antibodies Deutsche Medizinische Wochenschrift 97(34): 1264-1266
Skripnichenko, D.F.; Krivitskiĭ, D.I. 1983: Differentiated volume of thyroid gland resection in toxic goiter patients Klinicheskaia Khirurgiia 1983(12): 29-32
Aleksandrova, G.F.; Vnotchenko, S.L.; Konnova, E.V.; Iur'eva, N.P. 1981: Method of determining autoantibodies to thyroid antigens in diffuse toxic goiter and Hashimoto's thyroiditis Sovetskaia Meditsina 5: 36-39
Khelds, A.O. 1986: Normalization of the functional regulation of the thyroid as a criterion of the remission of diffuse toxic goiter following antithyroid treatment Problemy Endokrinologii 32(4): 11-14
Ganieva, G.M.; Shadlinskiĭ, V.B.; Gogiashvili, L.E.; Tsagareli, Z.G. 2013: Parameters of thyroid glands functional units in diffuse toxic and nodular euthyroid goiter in population of border areas of Azerbaijan and Georgia Georgian Medical News 218: 67-72
Sekhniashvili, Z.S. 1988: Immunological characteristics of patients with diffuse toxic goiter Problemy Endokrinologii 34(2): 3-5
Dlugach, E.A.; Aleksandrova, G.F.; Mel'nichenko, G.A. 1993: Principles of training patients with diffuse toxic goiter Problemy Endokrinologii 39(4): 31-33
Petrov, N.M. 1986: Lithium carbonate in the treatment of patients with diffuse toxic goiter Vrachebnoe Delo 6: 64-66
Rom-Bugoslavskaia, E.S.; Somova, E.V.; Grinchenko, T.S.; Kravchun, N.A.; Romanova, I.P.; Mishura, A.I. 1998: Lipid peroxidation in patients with diffuse toxic goiter and hypothyroidism Likars'ka Sprava 1: 88-91
Cheren'ko, M.P. 1972: Development of primary diffuse toxic goiter in a patient previously subjected to surgery for euthyroid nodular goiter Klinicheskaia Khirurgiia 9: 72-73
Epishin, A.V. 1984: Immunologic reactions in patients with diffuse toxic goiter after mercasolyl treatment Klinicheskaia Meditsina 62(8): 90-93
Livshits, A.Kh.; Oleĭnik, E.K. 1985: Changes in the immune status indices of patients with diffuse toxic goiter in different stages of the disease Problemy Endokrinologii 31(6): 6-10
Schicha, H.; Dietlein, M. 2002: Graves' disease nd toxic nodular goiter--radioiodine therapy NUKLEARMEDIZIN. Nuclear Medicine 41(2): 63-70
Borodina, L.V. 1987: Amino acid composition of the blood in patients with diffuse toxic goiter during conservative therapy Terapevticheskii Arkhiv 59(6): 100-103
Baranov, V.G.; Potin, V.V.; Stepanov, G.S.; Shliakhtina, L.G. 1970: Characteristics of the biological effect of the thyrotropic activity of the blood of diffuse toxic goiter patients Problemy Endokrinologii 16(6): 27-33
Alesov, V.Z. 1976: A comparative assessment of the efficacy of antithyroid therapy in patients with nodular and diffuse toxic goiter Problemy Endokrinologii 22(1): 12-15
Berger, H.; Glatzl, J.; Riccabona, G.; Haberfellner, H. 1973: The thyroid gland scintigram as a method for determination of the thyroid gland size in children from endemic goiter districts Acta Endocrinologica. Supplementum 179: 71-72
Gaĭdina, G.A.; Gol'ber, L.M.; Kalenova, N.P.; Lazareva, S.P.; Prikhozhan, V.M. 1977: Reflex excitability of the spinal centers in patients with diffuse toxic goiter (concerning the pathogenesis of motor disorders) Problemy Endokrinologii 23(5): 24-29